Sun, Jul 13, 2014, 9:35 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Cytosorbents Corporation Message Board

buymyask 125 posts  |  Last Activity: Jun 20, 2014 2:32 PM Member since: Oct 20, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Hey cars

    by proudamerican79th Jun 20, 2014 10:48 AM
    buymyask buymyask Jun 20, 2014 2:32 PM Flag

    copitzdonde you are a fool. I've stated 1,000,000x I am not this idiot proudamerican. If I was would I be calling him an idiot LOL? He bashes this stock with non-sense and none of his posts make sense. Everyone should just block him.

    Going to be in atlantic city this weekend for anyone who wants to roll the dice w me!?

  • Reply to

    When BMA stops trading....

    by buymyask Jun 19, 2014 12:13 PM
    buymyask buymyask Jun 20, 2014 1:13 PM Flag

    roseky - hasn't been much to talk about. That is why no one is trading the stock and volume died down. Kind of just a waiting game now to hear about 1.) Sales for Q2 2.) FDA update

  • Reply to

    CytoSorb Q2 sales esimates?

    by cars100cars Jun 19, 2014 11:17 AM
    buymyask buymyask Jun 19, 2014 4:17 PM Flag

    There is no bashing for the millionth time. This is conversation. None of you are going to buy/sell stock and cause price to move based off of my remarks or ANYONE's remarks on this message board.

    I am devils advocate and play it quite well. Had 6.8M now have around 4M. I think the opportunity to make a quick buck is fading so that is why 2.8M was sold. The core position will still remaing untouched but the trading position is being exited in anticipation the sales for Q2 will be bad and the stock will fall to $0.16-$0.18 by August-ish.

    Some may go "oh you are missing out on the big run" .... Others who know what I am doing understand I am limiting risk and taking money off the table because of the increased uncertainty facing this company. I think Cytosorb sales are about to level off a few Q's in a row and this will upset investors. That coupled with no new FDA news, etc.

  • Reply to

    CytoSorb Q2 sales esimates?

    by cars100cars Jun 19, 2014 11:17 AM
    buymyask buymyask Jun 19, 2014 3:37 PM Flag

    If it is so easy why is the market pricing in no increase in sales from Q1? Also, contracts do not necessarily mean revenue recognition in the quater the contract is signed, etc. Product has to be produced in facility, delievered to the consumer, and out of the hands of CTSO. That could take weeks and weeks.

    We will see what happens I guess. I am anticipating sales between $300K-$400K to be honest. I do not see them going above $550K. When Dr. Chan gave guidance he was 60% through Q2 I believe. He could have given ACTUAL SALES numbers as of then and then forecasted the remaining 40% of the quarter. Seems to me like he was trying to hide weak sales.

    Watch the PR will come out with the headline:

    "CTSO sets record sales for the quarter... compared to Q2 2013"

  • Reply to

    when is Dr. Chan planning on uplisting?

    by jcnbiz Jun 19, 2014 10:52 AM
    buymyask buymyask Jun 19, 2014 3:26 PM Flag

    Honestly - Game of Thrones has more credence than he does. Zacks has been prediciting $0.50 as of a year ago I believe LMAO.... These guys just build discounted CF models and plug in random assumptions. I could teach a high school student to do the same thing.

  • Reply to

    CytoSorb Q2 sales esimates?

    by cars100cars Jun 19, 2014 11:17 AM
    buymyask buymyask Jun 19, 2014 3:24 PM Flag

    Facts are Dr. Chan gave good guidance Q1 using actual numbers and then for Q2 he said greater sales than Q2 2013 as opposed to giving actual numbers. This would lead to the assumption sales are not strong in Q2....

  • Reply to

    when is Dr. Chan planning on uplisting?

    by jcnbiz Jun 19, 2014 10:52 AM
    buymyask buymyask Jun 19, 2014 1:13 PM Flag

    Oh boy. Here we go. CTSO will be acquired at a price of $10/share according to penny flipper LMAO....

    There is 0% chance of uplisting in 2014. I said this in Q1 and am still saying it with 50% of the year left to go. The fundamentals are NOT EVEN CLOSE to being in place. We are going to afford a $1M/year listing fee LOL?? That is 10% of the capital we raised in the previous round of financing/dilution.

    Also - not 1 company is planning to buy or even looking to buy CTSO. The message boards are notorious for magical buyout rumors. This isn't GAME OF THRONES penny flipper. No one is going to come and takeover the land and castle of CTSO.

  • Reply to

    CytoSorb Q2 sales esimates?

    by cars100cars Jun 19, 2014 11:17 AM
    buymyask buymyask Jun 19, 2014 1:10 PM Flag

    If you are right the stock price will rise significantly. However, I believe your expectations are unrealistic and CTSO will yield around $300K in sales in Q2. The market will be upset and the stock will sell off below $0.20.

  • Volume dies down a lot, huh? This is very interesting. No one wants to buy or sell :( ?

  • Reply to

    CytoSorb Q2 sales esimates?

    by cars100cars Jun 19, 2014 11:17 AM
    buymyask buymyask Jun 19, 2014 12:12 PM Flag

    Cars - have you not read the recent 10Q? Dr. Chan stated sales would be greater YoY - not QoQ. I am guessing sales will be around $300K. NO way they are in the $500K range IMHO. Also - CTSO will not be able to achieve that growth rate without an enormous partner, clinical data showing the product works OR fda approval.

  • Reply to

    Why buy?

    by honeybadger666666 Jun 16, 2014 11:35 AM
    buymyask buymyask Jun 19, 2014 12:11 PM Flag

    LOL... Everyone who questions the company on this site gets accused of being me haha... However, I have only posted under 2 names here ever and I have publicly stated both of those names.

    I would wait to buy after Q2 sales #'s are released. I have a huge feeling sales are going to be poor and they will not give any guidance for Q3 sales either. Biggest risk in next 1 year is that sales drop or flatten out. IF they are adding distributors and a sales force and sales level off that is a huge sign the market is not accepting the product as CTSO has anticipated they would. Biggest risk in next 2 years in running out of cash or not getting solid data for FDA approval.

    Solid support at $0.18 and resistance around $0.25. GLTU.

  • buymyask by buymyask Jun 17, 2014 6:14 AM Flag

    Some selling picked up yesterday. Could make a fall for $0.18-$0.20 again. Company has had zero news and the move above $0.24 was on so so volume.

  • buymyask buymyask Jun 8, 2014 4:55 PM Flag

    I have only posted under cpbball3 and stated that was my only other name. I have no connection to any of these other idiots posting on the board who bash ctso stock.. No one should listen to them at all. They post dumb information and its worthless and clutters the board. Also dr. L and me have had different ids on ihub for 4 years.... You cant have different ids on ihub. They track ip addresses and delete accounts. Also, i argued viciously with his position on the stock 4 years ago when i was a strong believer in the technology and he wasnt.

  • Reply to


    by petryandre33 Jun 7, 2014 8:59 AM
    buymyask buymyask Jun 7, 2014 6:38 PM Flag



  • Reply to

    How To "Power" a Trial

    by z3peru May 26, 2014 1:36 PM
    buymyask buymyask May 26, 2014 7:25 PM Flag

    Z3peru you have very good information in these posts for those who do not understand why statistical significance matters so much.

    Ideally i would like to see a 300+ person trial. I dont think a trial with 30-100 people is going to do anything.

  • buymyask by buymyask May 7, 2014 2:22 PM Flag

    Chart shows lower lows being made each day. $0.18 might be next stop if we fall past $0.202.

  • buymyask buymyask May 5, 2014 4:33 PM Flag

    I agree that $1M would move the stock a lot. However, you are telling me sales are going to increase around 90% QoQ? That is a huge "hope" you have there lol...

  • Reply to

    Serious replies only please.

    by getothetop1234 May 4, 2014 11:18 AM
    buymyask buymyask May 4, 2014 5:43 PM Flag

    Do yourself a favor and dont ask people on this board for advice. Ever. Read through the 10k and presentations Cytosorb puts out. Asking people on this board for advice is like asking drug addicts for their opinion on drugs.

  • Reply to

    Statistical Significance

    by croosader7 May 2, 2014 4:24 PM
    buymyask buymyask May 2, 2014 4:35 PM Flag

    "Oh we had a trial with 100 patients but 50 of them we aren't going to report what happened. But if you look at the 9 red headed females who are 65 or older and of mexican descent the mortality was 0% vs 43% (treated vs. control) with a p-value of 0.03"....

    That is basically what CTSO said in their publication. It was a complete joke. You can't take a subset of the 100 patients and analyze THAT DATA and get a p-value. Also, if you think you are right then I guess you are saying the entire stock market and all the investors in the world have it completely wrong and the stock should not be at $0.22 LOL.... Its an efficient market guy!

  • Reply to

    Statistical Significance

    by croosader7 May 2, 2014 4:24 PM
    buymyask buymyask May 2, 2014 4:31 PM Flag

    croosader you are a novice selling hot dogs at a lemonade stand. THEY SLICED AND DICED THE DATA BUDDY. THAT IS WHY NO ONE GAVE AN F WHEN THE RESULTS WERE PUBLISHED..

    You canot do a trial with 100 patients AND THEN THROW HALF THE DATA AWAY AND ANALYZE THE HALF THAT YOU WANT TO ANALYZE!!!!!!!!!!!!!!

    Also, if you were paying attention, no one stated they did not significantly reduce cytokines. I actually stated THEY DID with a PVALUE of 0.01 i believe! However, reduction in Cytokines does not have a meaningfull correlation to reduction in mortality or reduction of days in the ICU for patients.

    Let me know if you would like to explain this further because clearly you do not understand. I posted all the European trial data in a thread and explained it word for word, but, clearly you did not read that.

0.240.00(-0.83%)Jul 11 3:58 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.